Should I Buy INMB Stock in 2026?
Data-driven analysis and honest assessment for Inmune Bio Inc
Current Price: $1.29
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
P/E data not available
Slow growth of 1%
Currently unprofitable
Financial health data limited
Negative free cash flow
No recent insider activity
Key Investment Metrics
Current Price
$1.29
P/E Ratio
N/A
Revenue Growth
2.6%
Profit Margin
N/A
Market Cap
$0.0B
Dividend Yield
None
How INMB Compares to Competitors
Understanding how INMB stacks up against peers helps inform your investment decision.
How INMB Compares to Peers
Upcoming Events for INMB
+5 Reasons TO Buy INMB
1. High gross margins of 100%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy INMB
1. Negative free cash flow
high riskBurning cash creates funding risk and limits shareholder returns.
2. Small-cap volatility risk
high riskMarket cap under $2B means higher volatility and lower liquidity.
3. Minimal revenue growth
low riskGrowth of 2.6% barely keeps pace with inflation.
Who Should Buy INMB?
Investment Profile
Risk Level
Very High
Recommended Holding Period
3-5 years
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 3% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in INMB, compare these Health Care peers:
Pro tip: Compare INMB directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for INMB
Frequently Asked Questions
What is INMB stock price today?
INMB (Inmune Bio Inc) stock is trading at $1.29 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is INMB stock going up or down today?
INMB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy INMB stock now?
The decision to buy INMB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is INMB a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for INMB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is INMB stock overvalued or undervalued?
Use our DCF valuation calculator to determine if INMB is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is INMB's P/E ratio?
P/E ratio data for INMB will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is INMB's market cap?
INMB (Inmune Bio Inc) has a market capitalization of $0.03 billion, making it a small-cap stock.
What is INMB's price to book ratio?
INMB trades at a price-to-book (P/B) ratio of 1.33, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Inmune Bio Inc
Full Stock Analysis
Complete INMB overview with charts and data
Is INMB Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how INMB stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Inmune Bio Inc
Complete INMB Analysis
Compare INMB With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.